Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NFLX | Common Stock | Other | $0 | -237K | -100% | $0.00* | 0 | Jan 30, 2023 | TCV VII, L.P. | F1, F2 |
transaction | NFLX | Common Stock | Other | $0 | -123K | -100% | $0.00* | 0 | Jan 30, 2023 | TCV VII (A), L.P. | F3, F4 |
transaction | NFLX | Common Stock | Other | $0 | -2.05K | -100% | $0.00* | 0 | Jan 30, 2023 | TCV Member Fund, L.P. | F5, F6 |
transaction | NFLX | Common Stock | Other | $0 | +8.49K | +1.84% | $0.00 | 468K | Jan 30, 2023 | The Hoag Family Trust V/A DTD 08/02/1994 | F7, F8 |
transaction | NFLX | Common Stock | Other | $0 | +8.49K | +5.45% | $0.00 | 164K | Jan 30, 2023 | Hamilton Investments Limited Partnership | F9, F10 |
transaction | NFLX | Common Stock | Options Exercise | $27.2K | +232 | $117.22 | 232 | Jan 31, 2023 | Direct | F15 | |
transaction | NFLX | Common Stock | Options Exercise | $27.2K | +213 | +91.81% | $127.49 | 445 | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $27.2K | +193 | +43.37% | $140.78 | 638 | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $27.2K | +191 | +29.94% | $142.65 | 829 | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $27.2K | +185 | +22.32% | $146.92 | 1.01K | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $27.2K | +175 | +17.26% | $155.35 | 1.19K | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $27.2K | +167 | +14.05% | $162.99 | 1.36K | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $27.2K | +186 | +13.72% | $146.17 | 1.54K | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $27.1K | +149 | +9.66% | $182.03 | 1.69K | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $27.3K | +156 | +9.23% | $174.74 | 1.85K | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $27.3K | +154 | +8.34% | $177.01 | 2K | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $25.5K | +129 | +6.45% | $198.00 | 2.13K | Jan 31, 2023 | Direct | F15 |
transaction | NFLX | Common Stock | Options Exercise | $25.6K | +137 | +6.43% | $186.82 | 2.27K | Jan 31, 2023 | Direct | F15 |
holding | NFLX | Common Stock | 512K | Jan 30, 2023 | Orange Investor, L.P. | F11 | |||||
holding | NFLX | Common Stock | 138K | Jan 30, 2023 | Orange (A) Investor, L.P. | F12 | |||||
holding | NFLX | Common Stock | 31.8K | Jan 30, 2023 | Orange (B) Investor, L.P. | F13 | |||||
holding | NFLX | Common Stock | 37.7K | Jan 30, 2023 | Orange (MF) Investor, L.P. | F14 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -232 | -43.53% | $0.00 | 301 | Jan 31, 2023 | Common Stock | 232 | $117.22 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -213 | -43.47% | $0.00 | 277 | Jan 31, 2023 | Common Stock | 213 | $127.49 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -193 | -43.47% | $0.00 | 251 | Jan 31, 2023 | Common Stock | 193 | $140.78 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -191 | -43.61% | $0.00 | 247 | Jan 31, 2023 | Common Stock | 191 | $142.65 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -185 | -43.43% | $0.00 | 241 | Jan 31, 2023 | Common Stock | 185 | $146.92 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -175 | -43.53% | $0.00 | 227 | Jan 31, 2023 | Common Stock | 175 | $155.35 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -167 | -43.6% | $0.00 | 216 | Jan 31, 2023 | Common Stock | 167 | $162.99 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -186 | -43.46% | $0.00 | 242 | Jan 31, 2023 | Common Stock | 186 | $146.17 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -149 | -43.44% | $0.00 | 194 | Jan 31, 2023 | Common Stock | 149 | $182.03 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -156 | -43.58% | $0.00 | 202 | Jan 31, 2023 | Common Stock | 156 | $174.74 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -154 | -43.63% | $0.00 | 199 | Jan 31, 2023 | Common Stock | 154 | $177.01 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -129 | -40.82% | $0.00 | 187 | Jan 31, 2023 | Common Stock | 129 | $198.00 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -137 | -41.02% | $0.00 | 197 | Jan 31, 2023 | Common Stock | 137 | $186.82 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -109 | -35.05% | $0.00 | 202 | Jan 31, 2023 | Common Stock | 109 | $201.07 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -83 | -35.17% | $0.00 | 153 | Jan 31, 2023 | Common Stock | 83 | $265.07 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -75 | -34.88% | $0.00 | 140 | Jan 31, 2023 | Common Stock | 75 | $290.39 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -78 | -34.98% | $0.00 | 145 | Jan 31, 2023 | Common Stock | 78 | $280.29 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -70 | -35.18% | $0.00 | 129 | Jan 31, 2023 | Common Stock | 70 | $313.30 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -65 | -35.14% | $0.00 | 120 | Jan 31, 2023 | Common Stock | 65 | $338.38 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -69 | -35.03% | $0.00 | 128 | Jan 31, 2023 | Common Stock | 69 | $317.38 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -76 | -35.19% | $0.00 | 140 | Jan 31, 2023 | Common Stock | 76 | $290.30 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -82 | -35.19% | $0.00 | 151 | Jan 31, 2023 | Common Stock | 82 | $267.66 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -65 | -35.33% | $0.00 | 119 | Jan 31, 2023 | Common Stock | 65 | $339.85 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -65 | -34.95% | $0.00 | 121 | Jan 31, 2023 | Common Stock | 65 | $336.63 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -68 | -34.87% | $0.00 | 127 | Jan 31, 2023 | Common Stock | 68 | $319.50 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -76 | -35.19% | $0.00 | 140 | Jan 31, 2023 | Common Stock | 76 | $289.29 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -81 | -34.91% | $0.00 | 151 | Jan 31, 2023 | Common Stock | 81 | $269.58 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -76 | -34.86% | $0.00 | 142 | Jan 31, 2023 | Common Stock | 76 | $286.81 | Direct | F15, F16 |
transaction | NFLX | Non-qualified Stock Option (right to buy) | Options Exercise | $0 | -71 | -35.15% | $0.00 | 131 | Jan 31, 2023 | Common Stock | 71 | $309.99 | Direct | F15, F16 |
Id | Content |
---|---|
F1 | In kind pro-rata distribution from TCV VII, L.P. ("TCV VII") to its partners, without consideration. |
F2 | These shares are directly held by TCV VII. Jay C. Hoag is a Class A Director of Technology Crossover Management VII, Ltd. ("Management VII") and a limited partner of Technology Crossover Management VII, L.P. ("TCM VII"). Management VII is the sole general partner of TCM VII, which is the sole general partner of TCV VII. Mr. Hoag may be deemed to beneficially own the shares held by TCV VII but disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F3 | In kind pro-rata distribution from TCV VII (A), L.P. ("TCV VII (A)") to its partners, without consideration. |
F4 | These shares are directly held by TCV VII (A). Jay C. Hoag is a Class A Director of Management VII and a limited partner of TCM VII. Management VII is the sole general partner of TCM VII, which is the sole general partner of TCV VII (A). Mr. Hoag may be deemed to beneficially own the shares held by TCV VII (A) but disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F5 | In kind pro-rata distribution from TCV Member Fund, L.P. ("Member Fund") to its partners, without consideration. |
F6 | These shares are directly held by Member Fund. Jay C. Hoag is a limited partner of Member Fund and a Class A Director of Management VII. Management VII is a general partner of Member Fund. Mr. Hoag may be deemed to beneficially own the shares held by Member Fund but disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F7 | Acquisition by The Hoag Family Trust V/A DTD 08/02/1994 pursuant to an in kind pro-rata distribution by each of the Member Fund and TCM VII, without consideration. |
F8 | These shares are held by The Hoag Family Trust U/A DTD 08/02/1994. Jay C. Hoag is a trustee of The Hoag Family Trust U/A DTD 08/02/1994. Mr. Hoag disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F9 | Acquisition by Hamilton Investments Limited Partnership pursuant to an in kind pro-rata distribution by each of the Member Fund and TCM VII, without consideration. |
F10 | These shares are held by Hamilton Investments Limited Partnership. Jay C. Hoag is the general partner of Hamilton Investments Limited Partnership. Mr. Hoag disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F11 | These shares are directly held by Orange Investor, L.P. ("Orange Investor"). Jay C. Hoag is a Class A Director of Technology Crossover Management VIII, Ltd. ("Management VIII") and a limited partner of Technology Crossover Management VIII, L.P ("TCM VIII"). Management VIII is the sole general partner of TCM VIII, which in turn is the sole general partner of TCV VIII, L.P., which in turn is the sole member of Orange Investor GP, LLC ("Orange GP"), which in turn is the sole general partner of Orange Investor. Mr. Hoag may be deemed to beneficially own the shares held by Orange Investor but disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F12 | These shares are directly held by Orange (A) Investor, L.P. ("Orange (A) Investor"). Jay C. Hoag is a Class A Director of Management VIII and a limited partner of TCM VIII. Management VIII is the sole general partner of TCM VIII, which in turn is the sole general partner of TCV VIII, L.P., which in turn is the sole member of Orange GP, which in turn is the sole general partner of Orange (A) Investor. Mr. Hoag may be deemed to beneficially own the shares held by Orange (A) Investor but disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F13 | These shares are directly held by Orange (B) Investor, L.P. ("Orange (B) Investor"). Jay C. Hoag is a Class A Director of Management VIII and a limited partner of TCM VIII. Management VIII is the sole general partner of TCM VIII, which in turn is the sole general partner of TCV VIII, L.P., which in turn is the sole member of Orange GP, which in turn is the sole general partner of Orange (B) Investor. Mr. Hoag may be deemed to beneficially own the shares held by Orange (B) Investor but disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F14 | These shares are directly held by Orange (MF) Investor, L.P. ("Orange (MF) Investor"). Jay C. Hoag is a Class A Director of Management VIII. Management VIII is the sole general partner of TCM VIII, which in turn is the sole general partner of TCV VIII, L.P., which in turn is the sole member of Orange GP, which in turn is the sole general partner of Orange (MF) Investor. Mr. Hoag may be deemed to beneficially own the shares held by Orange (MF) Investor but disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F15 | Jay C. Hoag has sole voting and dispositive power over the options he holds directly. However, TCV VII Management, L.L.C. has a right to 100% of the pecuniary interest in such options. Mr. Hoag is a Member of TCV VII Management, L.L.C. Mr. Hoag disclaims beneficial ownership of such options and the shares to be received upon the exercise of such options except to the extent of his pecuniary interest therein. |
F16 | Jay C. Hoag has sole voting and dispositive power over the remaining options he holds directly. However, TCV VIII Management, L.L.C. has a right to 100% of the pecuniary interest in such remaining options. Mr. Hoag is a Member of TCV VIII Management, L.L.C. Mr. Hoag disclaims beneficial ownership of such options and the shares to be received upon the exercise of such options except to the extent of his pecuniary interest therein. |
This is the first part of a Form 4 filing for the Reporting Person. There are two parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.